With three centers of excellence for memory and movement disorders, Banner Alzheimer’s Institutes in Phoenix and Tucson, Ariz. and Banner Sun Health Research Institute in Sun City, Ariz., Banner Health has gained global recognition for its commitment to these disorders. Since 2006, the institutes have received more than $400 million in Banner-led grants from National Institutes of Health, $116 million in philanthropic donations and $2 billion in additional investments. The institutes have been responsible for multiple contributions to Alzheimer’s research, detection and treatment. These include the discovery of a rare genetic trait, as well as now opening a pathway to delay the onset of Alzheimer’s in people who risk developing the disease. These prevention therapies avert the onset of cognitive impairment in healthy people with blood test evidence of the disease within two years and a treatment that completely averts onset of Alzheimer’s disease in at-risk people within four years. The institutes played an industry-leading role in the FDA approval of two prevention therapies for early symptomatic Alzheimer’s disease. Establishment of the fluid biomarker program will play a leading role to find simpler, easier and less costly ways to evaluate a person’s risk. Banner Health totaled over 20,000 clinic visits across the specialty centers in 2024, with care provided by 28 employed providers, including subspecialty trained cognitive behavioral and movement disorder physicians, advanced practice providers, neuropsychologists and licensed clinical social workers.
Back to list


Becker's Recognition
Banner Alzheimer’s Institute and Banner Sun Health Research Institutehas been named a Becker's honoree on the lists below.
2025 Winner

2025 Winner

